Daiichi Sankyo, Inc.


About Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is
headquartered in Basking Ridge, New Jersey, and is focused on the development
of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in
the U.S. include the rapies for metastatic breast cancer, gastric cancer,
tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis,
stroke risk reduction, acute coronary syndrome, and I V iron therapy.